The executive committee of the supervisory board of Evonik Industries AG has proposed to the supervisory board to give its consent to the termination of the board position of Dr Wolfgang Colberg (53) as chief financial officer in best mutual agreement with effect to September 30, 2013. Dr Colberg is the chief financial officer of Evonik since April 1, 2009.
Moreover, the executive committee of the supervisory board of Evonik Industries AG has proposed to the supervisory board to appoint Ms Ute Wolf (45) as chief financial officer with effect from October 1, 2013. Ms Wolf is head of finance of Evonik since January 1, 2006.
The final decision is to be made by the supervisory board of Evonik Industries AG which is expected to resolve on this on June 21, 2013.
About Evonik
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
